Skip to main content
Retour
Watch Compare

GeoVax Labs, Inc.

Qualité des données : 83%
GOVX
Nasdaq Manufacturing Chemicals
1,16 €
▼ 0,02 € (-1,69%)
Cap. Boursière: 2,58 M
Prix
1,16 €
Cap. Boursière
2,58 M
Fourchette du Jour
1,14 € — 1,20 €
Fourchette 52 Semaines
1,14 € — 34,75 €
Volume
61 970
Ouverture 1,19 €
Moyenne 50J / 200J
1,93 €
39,87% below
Moyenne 50J / 200J
10,78 €
89,24% below

Quick Summary

Points Clés

Negative free cash flow of -24,29 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-654,97%
En dessous de la moyenne du secteur (-51,02%)
ROIC-522,18%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio3,57
Interest CoverageN/A

Valorisation

PE (TTM)
-0,10
Au-dessus de la moyenne du secteur (-1,98)
P/B Ratio0,53
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -0,1 -2,0
P/B 0,5 5,1
ROE % -655,0 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -25,31 M
ROE -654,97% ROA -418,97%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -24,29 M
ROIC -522,18% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,57
Interest Coverage N/A Asset Turnover N/A
Working Capital 4,69 M Tangible Book Value 4,91 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,10 Forward P/E N/A
P/B Ratio 0,53 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -941,84%
Market Cap 2,58 M Enterprise Value -2,43 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -10,93 OCF / Share -10,91
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 95,99%
SBC-Adj. FCF -25,29 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -24,99 M -25,97 M -14,02 M -18,57 M -2,96 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -25,14 M -26,74 M -14,03 M -18,75 M -2,82 M
EBITDA — — — — —
R&D Expenses 23,71 M 20,72 M 9,12 M 15,55 M 2,44 M
SG&A Expenses — — — — —
D&A 95 368,0 74 169,0 56 284,0 38 521,0 19 656,0
Interest Expense 21 375,0 — 0,0 1 286,0 143 524,0
Income Tax — — — 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 8,16 M 9,28 M 31,35 M 11,80 M 10,39 M
Total Liabilities — — 4,75 M 7,44 M 825 047,0
Shareholders' Equity 5,05 M 5,76 M 26,60 M 4,36 M 9,57 M
Total Debt — — — — —
Cash & Equivalents 5,51 M 6,45 M 27,61 M 11,42 M 9,88 M
Current Assets 7,93 M 7,89 M 28,94 M 11,63 M 10,24 M
Current Liabilities 3,11 M 3,52 M 4,75 M 5,44 M 810 309,0